Chargement en cours...
ADRB1 was identified as a potential biomarker for breast cancer by the co-analysis of tumor mutational burden and immune infiltration
Breast cancer (BRCA) has traditionally been considered as having poor immunogenicity and is characterized by relatively low tumor mutational burden (TMB). Improving immunogenicity may improve the response to clinical immunotherapy of BRCA. However, the relationship between TMB, immune infiltration,...
Enregistré dans:
| Publié dans: | Aging (Albany NY) |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Impact Journals
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7835009/ https://ncbi.nlm.nih.gov/pubmed/33234738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.104204 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|